The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Bikbov M.M.

GBU "Ufimskiĭ NII glaznykh bolezneĭ" AN Respubliki Bashkortostan

Babushkin A.É.

GBU "Ufimskiĭ NII glaznykh bolezneĭ" AN Respubliki Bashkortostan

Orenburkina O.I.

GBU "Ufimskiĭ NII glaznykh bolezneĭ" AN Respubliki Bashkortostan

Anti-VEGF-agents in treatment of neovascular glaucoma

Authors:

Bikbov M.M., Babushkin A.É., Orenburkina O.I.

More about the authors

Journal: Russian Annals of Ophthalmology. 2012;128(5): 50‑53

Read: 1651 times

Download PDF (RU)
Contact the author
Table of contents

ANTI-VEGF-AGENTS IN TREATMENT OF NEOVASCULAR GLAUCOMA
ANTI-VEGF-AGENTS IN TREATMENT OF NEOVASCULAR GLAUCOMA

To cite this article:

Bikbov MM, Babushkin AÉ, Orenburkina OI. Anti-VEGF-agents in treatment of neovascular glaucoma. Russian Annals of Ophthalmology. 2012;128(5):50‑53. (In Russ.)

Подписка 2026 Вестник офтальмологии (Russian Annals of Ophthalmology)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Neovascular glaucoma (NVG) is one of the most severe form of refractory glaucoma. Vascular endothelial growth factor (VEGF) is one of the strongest promoters of angiogenesis and was found to be the main neovascularization regulator. The use of anti-VEGF-agents is a rational option because in the majority of cases it allows to reach disappearance or reduction of neovascularization, that significantly reduces the risk of complications in following surgery or laser treatment of NVG.

Keywords:

refractory neovascular glaucoma
anti-VEGF-agents

Authors:

Bikbov M.M.

GBU "Ufimskiĭ NII glaznykh bolezneĭ" AN Respubliki Bashkortostan

Babushkin A.É.

GBU "Ufimskiĭ NII glaznykh bolezneĭ" AN Respubliki Bashkortostan

Orenburkina O.I.

GBU "Ufimskiĭ NII glaznykh bolezneĭ" AN Respubliki Bashkortostan

Close metadata

References:

  1. Belyi Yu.A., Tereshchenko A.V., Molotkova I.A. Primenenie anti-VEGF preparatov v lechenii neovaskulyarnoi glaukomy. Sbornik nauch. trudov nauch.-prakt. konf. po oftal'mokhirurgii s mezhdunarodnym uchastiem "Vostok-Zapad". Ufa 2011; 171-173.
  2. Bikbov M.M., Babushkin A.E., Orenburkina O.I. Rezul'taty khirurgicheskogo lecheniya neovaskulyarnoi glaukomy s ispol'zovaniem blokatorov VEGF. Klin oftal'mol 2011; 12: 1: 21-22.
  3. Vasil'ev R.A., Karlova E.V., Zolotarev A.V., Malyshev A.S. Khirurgicheskoe lechenie neovaskulyarnoi glaukomy na glazakh s vysokimi zritel'nymi funktsiyami. Sbornik tezisov IX Vseross. nauch.-prakt. konf. s mezhdunarodnym uchastiem "Fedorovskie chteniya-2011". M 2011; 293-293.
  4. Kasimov E.M., Askerova L.A. Otdalennye rezul'taty novogo kombinirovannogo metoda lecheniya neovaskulyarnoi glaukomy: sinustrabekulektomiya s implantatsiei silikonovogo drenazha posle intravitreal'nogo vvedeniya bevatsizumaba (avastin). Oftal'mol ved 2009; II: 3: 23-29.
  5. Krylov V.A., Rozenkrants M.K., Afonina E.V. Rezul'taty kombinirovannogo primeneniya anti-VEGF-terapii s implantatsiei klapana Akhmeda pri neovaskulyarnoi glaukome u patsientov s sakharnym diabetom. Sbornik tezisov IX Vseross. nauch.-prakt. konf. s mezhdunarodnym uchastiem "Fedorovskie chteniya-2011". M 2011; 317-317.
  6. Kushnir V.N., Rusu A.A., Kushnir V.V. Primenenie avastina dlya profilaktiki oslozhnenii pri khirurgicheskom lechenii neovaskulyarnoi glaukomy. VIII Vseross. nauch.-prakt. konf. s mezhdunarodnym uchastiem "Fedorovskie chteniya-2009". M 2009; 247-248.
  7. Robustova O.V., Bessmertnyi A.M. Sovremennye predstavleniya ob etiologii i patogeneze neovaskulyarnoi glaukomy. Glaukoma 2003: 4: 58-63.
  8. Surguch V.K., Erichev V.P. Antiangiogennaya terapiya pri neovaskulyarnoi glaukome. Glaukoma 2010: 2: 55-58.
  9. Takhchidi Kh.P., Metaev S.A., Cheglakov P.Yu., Tillyakhodzhaev S.S. Primenenie blokatorov VEGF v khirurgii neovaskulyarnoi glaukomy. V Evro-Aziatskaya konf. po oftal'mokhirurgii: Materialy. Ekaterinburg 2009; 154-155.
  10. Beutel J., Peters S., Lyeke M. et al. Bevacizumab as adjuvant for neovascular glaucoma. Acta Ophthalmol 2008; 20.
  11. Canut M.I., Alvarez A., Nadal J. et al. Anterior segment changes following intravitreal bevacizumab injection for treatment of neovascular glaucoma. Clin Ophthalmol 2011; 5: 715-719.
  12. Shalam K.V., Gupta S.K., Grover S. Intracameral avastin dramatically resolves iris neovascularization and reverser neovascular glaucoma. Eur J Ophthalmol 2008; 18: 2: 255-262.
  13. Cheng J., Wong D., Chong L. Intraocular avastin (Bevacizumab) for neovascularisation of the iris and neovascular glaucoma. Ann Acad Med Singapore 2008; 37: 72-74.
  14. Chilov M.N., Grigg J.R., Playfair T.J. Bevacizumab (avastin) for the treatment of neovascular glaucoma. Clin Exp Ophthalmology 2007; 35: 494-496.
  15. Davidorf F.H., Mouser J.G., Derick R.J. Rapid improvement of rubeosis from a single bevacizumab (Avastin) injection. Retina 2006: 26: 354-356.
  16. Duch S., Buchacra O., Milla E. et al. Intracameral bevacizumab (Avastin) for neovascular glaucoma: a pilot study in 6 patients. Glaucoma 2009; 18: 2: 140-143.
  17. Ehlers J.P., Spirn M.J., Lam A. et al. Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma. Retina 2008; 28: 5: 696-702.
  18. Gheith M.E., Siam G.A. et al. Role of intravitreal bevacizumab in neovascular glaucoma. Ocular Pharmacol Ther 2007; 23: 5: 487-491.
  19. Ghosh S., Singh D., Ruddle J.B. et al. Combined diode laser cyclophotocoagulation and intravitreal bevacizumab (Avastin) in neovascular glaucoma. Clin Exper Ophthalmol 2010; 38: 4: 353-357.
  20. Greval D.S., Jain R., Kumar H. et al. Evaluation of subconjuctival bevacizumab as an adjunct to trabeculectomy a pilot study. Ophthalmology 2008; 115: 12: 2141-2145.
  21. Gupta V., Jha R., Rao A., Kong G. The effect of different doses of intracameral bevacizumab on surgical outcomes of trabeculectomy for neovascular glaucoma. Eur J Ophthalmol 2009; 19: 3: 435-441.
  22. Ichhpujani P., Ramasubramanain A., Kaushik S., Pavdav S.S. Bevacizumab in glaucoma: a review. Canadian J Ophthalmol 2007; 42: 812-815.
  23. Iliev M.E., Domig D., Wolf-Schnurrbursch U. et al. Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma. Am J Ophthalmol 2006; 142: 1054-1056.
  24. Jiang Y., Liang X., Li X. et al. Analysis of the clinical efficacy of intravitreal bevacizumab in the treatment of iris neovascularization caused by proliferative diabetic retinopathy. Acta Ophthalmol 2008; 18.
  25. Jonas J.B., Spandau U.H., Schlichtenbrede F. Intravitreal bevacizumab for filtering surgery. Ophthalmic Res 2007; 39: 121-122.
  26. Kahook M.Y., Schuman J.S., Noecker R.J. Needle bleb revision of encapsulated filtering bleb with bevacizumab. Ophthalmic Surg Lasers Imaging 2006; 37: 148-150.
  27. Kahhook M.Y., Schuman J.S., Noecker R.J. Intravitreal bevacizumab in a patient with neovascular glaucoma. Ophthalmic Surg Lasers Imaging 2006; 37: 144-146.
  28. Kitnarong N., Chindasub P., Metheetrairut A. Surgical outcome of intravitreal bevacizumab and filtration surgery in neovascular glaucoma. Adv Ther 2008; 25: 438-443.
  29. Kotecha A., Spratt A., Ogunbowale L. et al. Intravitreal bevacizumab in refractory neovascular glaucoma. Arch. Ophthalmol 2011; 129: 2: 145-150.
  30. Lupinacci A.P., Calzada J.I., Rafieetery M. et al. Clinical outcomes of patients with anterior segment neovascularization treated with or without intraocular bevacizumab. Adv Ther 2009; 26: 2: 208-216.
  31. Moraczewski A.L., Lee R.K., Palmberg P.F. et al. Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab. Br J Ophthalmol 2009; 93: 5: 589-593.
  32. Rosenfeld P.J., Fung A.E., Puliafito C.A. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 2005; 36: 4: 336-339.
  33. Takihara Y., Inatani M., Kawaji T. et al. Combined intravitreal bevacizumab and trabeculectomy with mitomycin C versus trabeculectomy with mitomycin C alone for neovascular glaucoma. Glaucoma 2011; 20: 3: 196-201.
  34. Vatavuk Z., Bencic G., Mandic Z. Intravitreal bevacizumab for neovascular glaucoma following central retinal artery occlusion. Eur J Ophthalmol 2007; 17: 269-271.
  35. Wakabayashi T., Oshima Y., Sakaguchi H. et al. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Ophthalmology 2008; 115: 1571-1580.
  36. Wolf A., Von Jagow B., Ulbig M., Haritoglou C. et al. Intracameral injection of bevacizumab for the treatment of neovascular glaucoma. Ophthalmologica 2011; 226: 2: 51-56.
  37. Yazdani S., Hendi K., Pakravan M. Intravitreal bevacizumab (avastin) injection for neovascular glaucoma. Glaucoma 2007; 16: 437-439.
  38. Yuzbasioglu E., Artunay O., Rasier R. et al. Simultaneous intravitreal and intracameral injection of bevacizumab (Avastin) in neovascular glaucoma. Ocular Pharmacol Ther 2009; 25: 3: 259-264.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.